X0306 4 2019-03-28 1 0001624899 STERIS plc STE 0001237389 WILSON LOYAL W C/O RUTHERFORD HOUSE, STEPHENSONS WAY CHADDESDEN DERBY X0 DE21 6LY UNITED KINGDOM 1 0 0 0 Ordinary Shares, 10 pence par value 2019-03-28 4 D 0 29156 D 0 D Director Stock Option (right to buy) 32.34 2019-03-28 4 D 0 3133 D 2020-08-04 Ordinary Shares 3133 0 D Director Stock Option (right to buy) 31.61 2019-03-28 4 D 0 3121 D 2021-08-03 Ordinary Shares 3121 0 D Director Stock Option (right to buy) 32.36 2019-03-28 4 D 0 3218 D 2022-08-03 Ordinary Shares 3218 0 D Director Stock Option (right to buy) 64.05 2019-03-28 4 D 0 4110 D 2025-08-31 Ordinary Shares 4110 0 D Director Stock Option (right to buy) 71.40 2019-03-28 4 D 0 3781 D 2026-08-10 Ordinary Shares 3781 0 D Director Stock Option (right to buy) 86.23 2019-03-28 4 D 0 4058 D 2027-08-09 Ordinary Shares 4058 0 D Director Stock Option (right to buy) 114.74 2019-03-28 4 D 0 3495 D 2028-08-09 Ordinary Shares 3495 0 D Career Restricted Stock Units 2019-03-28 4 D 0 13899 0.00 D Ordinary Shares 13899 0 D Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,133 ordinary shares of STERIS for $32.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,121 ordinary shares of STERIS for $31.61 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,218 ordinary shares of STERIS for $32.36 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,110 ordinary shares of STERIS for $64.05 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,781 ordinary shares of STERIS for $71.40 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,058 ordinary shares of STERIS for $86.23 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,495 ordinary shares of STERIS for $114.74 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 13,899 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. /s/ Ronald E. Snyder, Authorized Representative under Power of Attorney 2019-03-28